These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12147092)

  • 21. Correlation between EGFr expression and accelerated proliferation during radiotherapy of head and neck squamous cell carcinoma.
    Pedicini P; Nappi A; Strigari L; Jereczek-Fossa BA; Alterio D; Cremonesi M; Botta F; Vischioni B; Caivano R; Fiorentino A; Improta G; Storto G; Benassi M; Orecchia R; Salvatore M
    Radiat Oncol; 2012 Aug; 7():143. PubMed ID: 22920680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of the microenvironment of head and neck cancers on tumor progression].
    Lukits J
    Magy Onkol; 2009 Mar; 53(1):51-9. PubMed ID: 19318327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterogeneity of primary site biopsies in head and neck squamous cell carcinoma.
    Moertel S; Ackermann H; Baghi M; Eckardt A; Wagenblast J; Stöver T; Hambek M
    Anticancer Res; 2011 Feb; 31(2):665-9. PubMed ID: 21378353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas.
    Szabó B; Nelhubel GA; Kárpáti A; Kenessey I; Jóri B; Székely C; Peták I; Lotz G; Hegedus Z; Hegedus B; Füle T; Döme B; Tímár J; Tóvári J
    Oral Oncol; 2011 Jun; 47(6):487-96. PubMed ID: 21498106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is immunohistochemical epidermal growth factor receptor expression overestimated as a prognostic factor in head-neck squamous cell carcinoma? A retrospective analysis based on a tissue microarray of 365 carcinomas.
    Fischer C; Zlobec I; Stöckli E; Probst S; Storck C; Tornillo L; Lugli A; Wolfensberger M; Terracciano L
    Hum Pathol; 2008 Oct; 39(10):1527-34. PubMed ID: 18620726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of EGFR in hypoxic, diffusion-limited areas of squamous cell carcinomas of the head and neck.
    Mayer A; Zahnreich S; Brieger J; Vaupel P; Schmidberger H
    Br J Cancer; 2016 Nov; 115(11):1351-1358. PubMed ID: 27802455
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of immunohistochemical markers in non-oropharyngeal head and neck squamous cell carcinoma in Ghana.
    Owusu-Afriyie O; Owiredu WKBA; Owusu-Danquah K; Komarck C; Foltin SK; Larsen-Reindorf R; Acheampong E; Quayson SE; Prince MEP; McHugh JB; Donkor P; Merajver SD; Brenner JC
    PLoS One; 2018; 13(8):e0202790. PubMed ID: 30138436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between p16 expression and high-risk human papillomavirus infection in squamous cell carcinomas from sites other than uterine cervix: a study of 137 cases.
    Doxtader EE; Katzenstein AL
    Hum Pathol; 2012 Mar; 43(3):327-32. PubMed ID: 21840041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Altered patterns of the interferon-inducible gene IFI16 expression in head and neck squamous cell carcinoma: immunohistochemical study including correlation with retinoblastoma protein, human papillomavirus infection and proliferation index.
    Azzimonti B; Pagano M; Mondini M; De Andrea M; Valente G; Monga G; Tommasino M; Aluffi P; Landolfo S; Gariglio M
    Histopathology; 2004 Dec; 45(6):560-72. PubMed ID: 15569046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The EGF receptor system in head and neck carcinomas and normal tissues. Immunohistochemical and quantitative studies.
    Christensen ME
    Dan Med Bull; 1998 Apr; 45(2):121-34. PubMed ID: 9587699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of c-erbB receptors, MMPs and VEGF in squamous cell carcinoma of the head and neck.
    Do NY; Lim SC; Im TS
    Oncol Rep; 2004 Aug; 12(2):229-37. PubMed ID: 15254682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial.
    Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD
    J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck.
    Eriksen JG; Steiniche T; Askaa J; Alsner J; Overgaard J
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):561-6. PubMed ID: 14751528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LOXL4 as a selective molecular marker in primary and metastatic head/neck carcinoma.
    Scola N; Görögh T
    Anticancer Res; 2010 Nov; 30(11):4567-71. PubMed ID: 21115907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survivin and pAkt as potential prognostic markers in squamous cell carcinoma of the head and neck.
    Pickhard A; Gröber S; Haug AK; Piontek G; Wirth M; Straßen U; Rudelius M; Reiter R
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Jun; 117(6):733-42. PubMed ID: 24726415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of tissue array technology in head and neck squamous cell carcinoma.
    Chen B; van den Brekel MW; Buschers W; Balm AJ; van Velthuysen ML
    Head Neck; 2003 Nov; 25(11):922-30. PubMed ID: 14603452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of c-MET in head and neck cancer: A systematic review and meta-analysis of aggregate data.
    Szturz P; Budíková M; Vermorken JB; Horová I; Gál B; Raymond E; de Gramont A; Faivre S
    Oral Oncol; 2017 Nov; 74():68-76. PubMed ID: 29103754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BMP-2 expression correlates with local failure in head and neck squamous cell carcinoma.
    Sand JP; Kokorina NA; Zakharkin SO; Lewis JS; Nussenbaum B
    Otolaryngol Head Neck Surg; 2014 Feb; 150(2):245-50. PubMed ID: 24247005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The expression of EGFR, cerbB2, p16, and p53 and their relationship with conventional parameters in squamous cell carcinoma of the larynx.
    Şimşek H; Han Ü; Önal B; Şimişek G
    Turk J Med Sci; 2014; 44(3):411-6. PubMed ID: 25558642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatial relationship of phosphorylated epidermal growth factor receptor and activated AKT in head and neck squamous cell carcinoma.
    Nijkamp MM; Hoogsteen IJ; Span PN; Takes RP; Lok J; Rijken PF; van der Kogel AJ; Bussink J; Kaanders JH
    Radiother Oncol; 2011 Oct; 101(1):165-70. PubMed ID: 21775008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.